Cartesian Therapeutics, Inc. 8-K

What Happened
Cartesian Therapeutics, Inc. (ticker: RNAC) announced its financial results for the quarter ended March 31, 2026. The company filed a Current Report on Form 8-K on April 30, 2026 under Item 2.02 (Results of Operations and Financial Condition) and furnished a press release reporting those results as Exhibit 99.1 to the filing.

Key Details

• Filing date: April 30, 2026.
• Reporting period: quarter ended March 31, 2026.
• Form 8-K Item: 2.02 — Results of Operations and Financial Condition.
• Exhibit furnished: 99.1 — press release with the announced quarterly results (104 Inline XBRL cover page included).

Why It Matters
This 8-K signals that Cartesian has released its latest quarterly earnings and financial condition update — information investors use to evaluate revenue, expenses, cash position, and operational progress. The press release attached to the filing contains the detailed numbers and any management commentary; investors should review that release and the company’s full SEC filings to see specific revenue, earnings (or losses), cash runway and any guidance or material operational updates that could affect the stock.